Zions Bancorp is a US regional bank with around $90 billion in total assets as of Dec... Show more
In recent weeks, ZION stock has exhibited upward momentum, climbing within a favorable range amid stabilizing macroeconomic conditions and sector tailwinds. The shares have benefited from robust profitability metrics and investor appreciation for the company's disciplined expense management and credit quality. Regional banks like Zions Bancorporation continue to navigate interest rate dynamics effectively, with deposit growth and controlled non-performing assets supporting balance sheet strength. This positioning has contributed to a constructive price trend in the latest market cycle, underscoring resilience in a competitive landscape.
Tickeron provides hundreds of AI Trading Bots—351 in total—that scan and trade thousands of tickers across stocks, ETFs, and cryptocurrencies, employing varied strategies, timeframes, and risk levels. Only the most promising ones, best aligned with current market volatility and conditions, appear on the curated Trending AI Robots page, which spotlights 25 elite performers. These include signal agents for quick 5-minute expert trades, intermediate 15- and 60-minute swings, and virtual agents using technical or fundamental analysis for low-to-high volatility environments. With real-time signals and copy-trading features, they offer diversified approaches to capture opportunities. Professional traders and investors may find value in reviewing these top-ranked bots to complement their strategies—visit the Trending AI Robots page today.
Zions Bancorporation's stock price has been influenced by key operational and strategic updates over the past 30 days. The standout event was the Q1 2026 earnings release on April 20, revealing net earnings of $232 million—a 38% year-over-year increase—and EPS of $1.56, exceeding analyst expectations of around $1.43. Revenues reached $860 million, up 6.7% from the prior year, though slightly below some forecasts due to elevated expenses. Notably, NII rose on a NIM expansion to 3.27%, fueled by deposit repricing and loan growth, while provisions for credit losses remained low, reflecting stable asset quality with minimal net charge-offs (NCOs, losses on loans). Fee income also expanded, supporting overall profitability. Initial post-earnings trading saw mild pressure from the revenue shortfall and higher non-interest expenses tied to technology investments, but sentiment quickly shifted positively on the EPS beat, margin improvement, and reaffirmed guidance, propelling shares higher in subsequent sessions.
Earlier, on March 23, Zions announced the acquisition of Basis Investment Group's Fannie Mae and Freddie Mac agency lending business line, a move to diversify into multifamily lending and capture government-sponsored enterprise (GSE) opportunities in the Western U.S. This strategic expansion enhances fee-generating capabilities and positions the bank for growth in a high-demand segment, boosting long-term revenue potential and contributing to upward price momentum.
Analyst reactions post-earnings further supported the stock. Firms like Citigroup raised their target to $66, Barclays to $72, DA Davidson to $78, and others including JP Morgan and RBC Capital adjusted upward, reflecting optimism around earnings quality and outlook. Consensus remains "Hold" with an average target near $67. Macro factors, including steady Federal Reserve rates and benign credit conditions in regional banking, have provided a supportive backdrop, with ZION outperforming peers on profitability metrics. These developments have driven an approximate 8% gain over recent weeks, linking clear fundamental progress to market behavior.
As Zions Bancorporation progresses through 2026, investors should track several pivotal themes grounded in recent guidance and industry dynamics. Management anticipates 7%-8% NII growth over the next 12 months under a no-rate-change scenario, with positive operating leverage of 100-150 basis points from revenue expansion outpacing expenses. Moderate increases in commercial and real estate loans are expected, alongside continued deposit growth amid shifting betas (interest rates paid on deposits). Credit quality remains a strength, with low NCOs and stable provisions, but vigilance on economic slowdown risks is essential.
Opportunities lie in the Basis acquisition's integration for GSE lending growth and fee income diversification, while technology upgrades could enhance efficiency. Risks include prolonged higher-for-longer rates compressing NIM, competitive pressures in the Western U.S., and regulatory scrutiny on capital (CET1, Common Equity Tier 1 ratio) and liquidity. Broader sector trends like M&A (mergers and acquisitions) activity and potential rate path shifts will influence positioning. Monitoring quarterly loan pipelines, deposit trends, and macroeconomic indicators will be crucial for assessing sustained performance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ZION declined for three days, in of 281 cases, the price declined further within the following month. The odds of a continued downward trend are .
The 10-day RSI Indicator for ZION moved out of overbought territory on April 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on May 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ZION as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for ZION turned negative on May 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for ZION crossed bullishly above the 50-day moving average on April 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZION advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .
ZION may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 233 cases where ZION Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ZION’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZION’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock worse than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.213) is normal, around the industry mean (1.160). P/E Ratio (9.262) is within average values for comparable stocks, (16.889). Projected Growth (PEG Ratio) (3.265) is also within normal values, averaging (3.316). Dividend Yield (0.030) settles around the average of (0.035) among similar stocks. P/S Ratio (2.551) is also within normal values, averaging (3.530).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
Industry RegionalBanks